# Evaluation of Dentifrice Formulations to Remineralize Enamel and Dentine Subsurface Lesions in a Double-Blind In-Situ Clinical Trial

> **NCT06140745** · NA · COMPLETED · sponsor: **Procter and Gamble** · enrollment: 10 (actual)

## Conditions studied

- Caries

## Interventions

- **DRUG:** 0 ppm Fluoride Dentifrice 1
- **DRUG:** 1100 ppm NaF Fluoride Dentifrice
- **DRUG:** 1500 ppm NaMFP Fluoride Dentifrice
- **DRUG:** 0 ppm Fluoride Dentifrice 2
- **DRUG:** 0 ppm Fluoride Dentifrice 3

## Key facts

- **NCT ID:** NCT06140745
- **Lead sponsor:** Procter and Gamble
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-05
- **Primary completion:** 2021-02-21
- **Final completion:** 2021-02-21
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06140745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06140745, "Evaluation of Dentifrice Formulations to Remineralize Enamel and Dentine Subsurface Lesions in a Double-Blind In-Situ Clinical Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06140745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*